Edwards Lifesciences Corp. (EW)
89.90
+0.12
(+0.13%)
USD |
NYSE |
Sep 04, 16:00
89.90
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Research and Development Expense (Quarterly) : 278.90M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 278.90M |
| March 31, 2026 | 263.30M |
| December 31, 2025 | 267.70M |
| September 30, 2025 | 280.70M |
| June 30, 2025 | 276.20M |
| March 31, 2025 | 254.60M |
| December 31, 2024 | 271.10M |
| September 30, 2024 | 253.40M |
| June 30, 2024 | 271.80M |
| March 31, 2024 | 256.70M |
| December 31, 2023 | 242.10M |
| September 30, 2023 | 242.80M |
| June 30, 2023 | 243.70M |
| March 31, 2023 | 261.20M |
| December 31, 2022 | 232.20M |
| September 30, 2022 | 233.60M |
| June 30, 2022 | 250.80M |
| March 31, 2022 | 228.60M |
| December 31, 2021 | 232.80M |
| September 30, 2021 | 238.00M |
| June 30, 2021 | 225.30M |
| March 31, 2021 | 207.00M |
| December 31, 2020 | 195.70M |
| September 30, 2020 | 195.50M |
| June 30, 2020 | 182.10M |
| Date | Value |
|---|---|
| March 31, 2020 | 187.40M |
| December 31, 2019 | 193.90M |
| September 30, 2019 | 195.50M |
| June 30, 2019 | 191.90M |
| March 31, 2019 | 171.40M |
| December 31, 2018 | 163.10M |
| September 30, 2018 | 161.80M |
| June 30, 2018 | 154.10M |
| March 31, 2018 | 143.20M |
| December 31, 2017 | 146.60M |
| September 30, 2017 | 142.90M |
| June 30, 2017 | 134.40M |
| March 31, 2017 | 128.70M |
| December 31, 2016 | 114.90M |
| September 30, 2016 | 113.00M |
| June 30, 2016 | 112.50M |
| March 31, 2016 | 101.80M |
| December 31, 2015 | 98.20M |
| September 30, 2015 | 101.00M |
| June 30, 2015 | 97.50M |
| March 31, 2015 | 86.40M |
| December 31, 2014 | 84.00M |
| September 30, 2014 | 87.60M |
| June 30, 2014 | 89.10M |
| March 31, 2014 | 85.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 370.40M |
| Stryker Corp. | 424.00M |
| Abbott Laboratories | 892.00M |
| Zimmer Biomet Holdings, Inc. | 104.80M |
| Solventum Corp. | 178.00M |